Clinical Trials Browser

Phase 1/2 × Recurrence × Panitumumab × Clear all

NCT01504477 2020-03-16

Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer

Phase 1/2 Terminated

6 enrolled 8 charts

Gastrointestinal

Recurrence, Colorectal Neoplasms